Northeast Financial Consultants Inc Horizon Therapeutics Public LTD CO Transaction History

Northeast Financial Consultants Inc

  • $2.16 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$62.39 - $113.8 $129,022 - $235,338
2,068 New
2,068 $235,000
Q2 2022

Aug 12, 2022
SELL
$79.4 - $116.36 $166,898 - $244,588
-2,102 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$91.91 - $110.37 $193,194 - $231,997
2,102 New
2,102 $230,000

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email